These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29791798)

  • 1. Non-Natural Linker Configuration in 2,6-Dipeptidyl-Anthraquinones Enhances the Inhibition of TAR RNA Binding/Annealing Activities by HIV-1 NC and Tat Proteins.
    Sosic A; Saccone I; Carraro C; Kenderdine T; Gamba E; Caliendo G; Corvino A; Di Vaio P; Fiorino F; Magli E; Perissutti E; Santagada V; Severino B; Spada V; Fabris D; Frecentese F; Gatto B
    Bioconjug Chem; 2018 Jul; 29(7):2195-2207. PubMed ID: 29791798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifaceted Aspects of HIV-1 Nucleocapsid Inhibition by TAR-Targeting Peptidyl-Anthraquinones Bearing Terminal Aromatic Moieties.
    Sosic A; Frecentese F; Olivato G; Rollo D; Carraro C; Gamba E; Santagada V; Gatto B
    Viruses; 2022 Sep; 14(10):. PubMed ID: 36298688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of HIV-1 Nucleocapsid Protein Inhibition by Lysyl-Peptidyl-Anthraquinone Conjugates.
    Sosic A; Sinigaglia L; Cappellini M; Carli I; Parolin C; Zagotto G; Sabatino G; Rovero P; Fabris D; Gatto B
    Bioconjug Chem; 2016 Jan; 27(1):247-56. PubMed ID: 26666402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic studies of mini-TAR RNA/DNA annealing in the absence and presence of HIV-1 nucleocapsid protein.
    Vo MN; Barany G; Rouzina I; Musier-Forsyth K
    J Mol Biol; 2006 Oct; 363(1):244-61. PubMed ID: 16962137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleic acid conformational changes essential for HIV-1 nucleocapsid protein-mediated inhibition of self-priming in minus-strand transfer.
    Hong MK; Harbron EJ; O'Connor DB; Guo J; Barbara PF; Levin JG; Musier-Forsyth K
    J Mol Biol; 2003 Jan; 325(1):1-10. PubMed ID: 12473448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discoveries of Tat-TAR interaction inhibitors for HIV-1.
    Yang M
    Curr Drug Targets Infect Disord; 2005 Dec; 5(4):433-44. PubMed ID: 16535863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of YB-1 with human immunodeficiency virus type 1 Tat and TAR RNA modulates viral promoter activity.
    Ansari SA; Safak M; Gallia GL; Sawaya BE; Amini S; Khalili K
    J Gen Virol; 1999 Oct; 80 ( Pt 10)():2629-2638. PubMed ID: 10573156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic HIV-1 Tat can dissociate HeLa nuclear protein-TAR RNA complexes in vitro: a novel Tat-nuclear protein interaction.
    Jeyapaul J; Seshamma T; Khan SA
    Oncogene; 1991 Sep; 6(9):1507-13. PubMed ID: 1923518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific HIV-1 TAR RNA loop sequence and functional groups are required for human cyclin T1-Tat-TAR ternary complex formation.
    Richter S; Cao H; Rana TM
    Biochemistry; 2002 May; 41(20):6391-7. PubMed ID: 12009901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region.
    Churcher MJ; Lamont C; Hamy F; Dingwall C; Green SM; Lowe AD; Butler JG; Gait MJ; Karn J
    J Mol Biol; 1993 Mar; 230(1):90-110. PubMed ID: 8450553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bis-3-Chloropiperidines Targeting TAR RNA as A Novel Strategy to Impair the HIV-1 Nucleocapsid Protein.
    Sosic A; Olivato G; Carraro C; Göttlich R; Fabris D; Gatto B
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33810333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
    Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
    J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in Vitro Screening of New Series of 2,6-Dipeptidyl-anthraquinones: Influence of Side Chain Length on HIV-1 Nucleocapsid Inhibitors.
    Frecentese F; Sosic A; Saccone I; Gamba E; Link K; Miola A; Cappellini M; Cattelan MG; Severino B; Fiorino F; Magli E; Corvino A; Perissutti E; Fabris D; Gatto B; Caliendo G; Santagada V
    J Med Chem; 2016 Mar; 59(5):1914-24. PubMed ID: 26797100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N-terminal zinc finger and flanking basic domains represent the minimal region of the human immunodeficiency virus type-1 nucleocapsid protein for targeting chaperone function.
    Mitra M; Wang W; Vo MN; Rouzina I; Barany G; Musier-Forsyth K
    Biochemistry; 2013 Nov; 52(46):8226-36. PubMed ID: 24144434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots".
    Davis B; Afshar M; Varani G; Murchie AI; Karn J; Lentzen G; Drysdale M; Bower J; Potter AJ; Starkey ID; Swarbrick T; Aboul-ela F
    J Mol Biol; 2004 Feb; 336(2):343-56. PubMed ID: 14757049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition.
    Hamy F; Brondani V; Flörsheimer A; Stark W; Blommers MJ; Klimkait T
    Biochemistry; 1998 Apr; 37(15):5086-95. PubMed ID: 9548739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
    Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
    Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Tat peptide binding to TAR RNA by electrospray ionization mass spectrometry.
    Sannes-Lowery KA; Hu P; Mack DP; Mei HY; Loo JA
    Anal Chem; 1997 Dec; 69(24):5130-5. PubMed ID: 9414617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.
    Wu F; Garcia J; Sigman D; Gaynor R
    Genes Dev; 1991 Nov; 5(11):2128-40. PubMed ID: 1936997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA binding by the tat and rev proteins of HIV-1.
    Karn J; Dingwall C; Finch JT; Heaphy S; Gait MJ
    Biochimie; 1991 Jan; 73(1):9-16. PubMed ID: 1903308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.